CATH Superfamily 2.60.120.970
The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 10: Transforming growth factor beta
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 32 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
6 | P01137 (/IPI) P01137 (/IPI) P04202 (/IPI) P04202 (/IPI) P07200 (/IPI) P18341 (/IPI) |
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
|
3 | P04202 (/TAS) P04202 (/TAS) P17246 (/TAS) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
3 | P01137 (/IPI) P01137 (/IPI) P07200 (/IPI) |
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
|
2 | P01137 (/IPI) P01137 (/IPI) |
Antigen binding GO:0003823
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
2 | P01137 (/IPI) P01137 (/IPI) |
Type II transforming growth factor beta receptor binding GO:0005114
Interacting selectively and non-covalently with a type II transforming growth factor beta receptor.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Transforming growth factor beta receptor binding GO:0005160
Interacting selectively and non-covalently with the transforming growth factor beta receptor.
|
2 | P04202 (/IPI) P04202 (/IPI) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
2 | P01137 (/IPI) P01137 (/IPI) |
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
2 | P01137 (/IPI) P01137 (/IPI) |
Type I transforming growth factor beta receptor binding GO:0034713
Interacting selectively and non-covalently with a type I transforming growth factor beta receptor.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
2 | P01137 (/IPI) P01137 (/IPI) |
Type III transforming growth factor beta receptor binding GO:0034714
Interacting selectively and non-covalently with a type III transforming growth factor beta receptor.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Protein serine/threonine kinase activator activity GO:0043539
Binds to and increases the activity of a protein serine/threonine kinase.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Protein N-terminus binding GO:0047485
Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
1 | P17246 (/IDA) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
1 | P17246 (/IDA) |
Protein N-terminus binding GO:0047485
Interacting selectively and non-covalently with a protein N-terminus, the end of any peptide chain at which the 2-amino (or 2-imino) function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
|
1 | P17246 (/IMP) |
There are 450 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Protein export from nucleus GO:0006611
The directed movement of a protein from the nucleus into the cytoplasm.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
ATP biosynthetic process GO:0006754
The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
SMAD protein complex assembly GO:0007183
The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of fibroblast migration GO:0010763
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Regulation of transforming growth factor beta receptor signaling pathway GO:0017015
Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Evasion or tolerance of host defenses by virus GO:0019049
Any process, either active or passive, by which a virus avoids or tolerates the effects of its host organism's defense(s). Host defenses may be induced by the presence of the virus or may be preformed (e.g. physical barriers). The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of cell-cell adhesion GO:0022408
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Hyaluronan catabolic process GO:0030214
The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Receptor catabolic process GO:0032801
The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of superoxide anion generation GO:0032930
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of protein dephosphorylation GO:0035307
Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of protein import into nucleus GO:0042307
Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of phosphatidylinositol 3-kinase activity GO:0043552
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Ossification involved in bone remodeling GO:0043932
The formation or growth of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in response to injury or other physical, physiological or environmental stress stimuli.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of mitotic cell cycle GO:0045930
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of isotype switching to IgA isotypes GO:0048298
Any process that activates or increases the frequency, rate or extent of isotype switching to IgA isotypes.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of skeletal muscle tissue development GO:0048642
Any process that stops, prevents, or reduces the frequency, rate or extent of skeletal muscle tissue development.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of chemotaxis GO:0050921
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of hyaluronan biosynthetic process GO:1900126
Any process that stops, prevents or reduces the frequency, rate or extent of hyaluronan biosynthetic process.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of NAD+ ADP-ribosyltransferase activity GO:1901666
Any process that activates or increases the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(52 more) |
Phosphate-containing compound metabolic process GO:0006796
The chemical reactions and pathways involving the phosphate group, the anion or salt of any phosphoric acid.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Extracellular matrix assembly GO:0085029
The aggregation, arrangement and bonding together of the extracellular matrix.
|
61 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(51 more) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
59 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(49 more) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
59 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(49 more) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
59 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(49 more) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
59 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(49 more) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
59 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(49 more) |
Negative regulation of gene silencing by miRNA GO:0060965
Any process that decreases the rate, frequency, or extent of gene silencing by miRNA.
|
50 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(40 more) |
Positive regulation of microglia differentiation GO:0014008
Any process that activates, maintains or increases the frequency, rate or extent of microglia differentiation, the process in which a relatively unspecialized cell acquires specialized features of a microglial cell.
|
13 |
O19011 (/ISS)
O19011 (/ISS)
P01137 (/ISS)
P01137 (/ISS)
P07200 (/ISS)
P09531 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
(3 more) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
12 |
O19011 (/ISS)
O19011 (/ISS)
P04202 (/ISS)
P04202 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(2 more) |
Membrane protein intracellular domain proteolysis GO:0031293
The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain.
|
12 |
O19011 (/ISS)
O19011 (/ISS)
P04202 (/ISS)
P04202 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(2 more) |
Regulation of SMAD protein signal transduction GO:0060390
Any process that modulates the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
12 |
O19011 (/ISS)
O19011 (/ISS)
P04202 (/ISS)
P04202 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(2 more) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
12 |
O19011 (/ISS)
O19011 (/ISS)
P04202 (/ISS)
P04202 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(2 more) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
11 |
O19011 (/ISS)
O19011 (/ISS)
P04202 (/ISS)
P04202 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
Q38HS2 (/ISS)
(1 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
11 |
O19011 (/ISS)
O19011 (/ISS)
P01137 (/ISS)
P01137 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(1 more) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
11 |
O19011 (/ISS)
O19011 (/ISS)
P04202 (/ISS)
P04202 (/ISS)
P07200 (/ISS)
P09533 (/ISS)
P17246 (/ISS)
P18341 (/ISS)
P50414 (/ISS)
P54831 (/ISS)
(1 more) |
Aortic valve morphogenesis GO:0003180
The process in which the structure of the aortic valve is generated and organized.
|
4 | P01137 (/IMP) P01137 (/IMP) P04202 (/IMP) P04202 (/IMP) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
4 | P01137 (/IMP) P01137 (/IMP) P04202 (/IMP) P04202 (/IMP) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Regulation of striated muscle tissue development GO:0016202
Any process that modulates the frequency, rate or extent of striated muscle development.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Regulation of protein import into nucleus GO:0042306
Any process that modulates the frequency, rate or extent of movement of proteins from the cytoplasm to the nucleus.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Lymph node development GO:0048535
The process whose specific outcome is the progression of lymph nodes over time, from their formation to the mature structure. A lymph node is a round, oval, or bean shaped structure localized in clusters along the lymphatic vessels, with a distinct internal structure including specialized vasculature and B- and T-zones for the activation of lymphocytes.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Regulation of binding GO:0051098
Any process that modulates the frequency, rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Regulation of DNA binding GO:0051101
Any process that modulates the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Extracellular matrix assembly GO:0085029
The aggregation, arrangement and bonding together of the extracellular matrix.
|
4 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
3 | P01137 (/IDA) P01137 (/IDA) P17246 (/IDA) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
3 | P04202 (/IDA) P04202 (/IDA) P17246 (/IDA) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
3 | P01137 (/IMP) P01137 (/IMP) P17246 (/IMP) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
3 | P01137 (/IDA) P01137 (/IDA) P17246 (/IDA) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Negative regulation of transcription by RNA polymerase II GO:0000122
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
|
2 | P04202 (/IGI) P04202 (/IGI) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
2 | P01137 (/IMP) P01137 (/IMP) |
MAPK cascade GO:0000165
An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain an additional tiers: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier to transmit a signal within a cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
2 | P04202 (/TAS) P04202 (/TAS) |
Vasculogenesis GO:0001570
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Vasculogenesis GO:0001570
The differentiation of endothelial cells from progenitor cells during blood vessel development, and the de novo formation of blood vessels and tubes.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Ureteric bud development GO:0001657
The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
|
2 | P04202 (/IEP) P04202 (/IEP) |
Morphogenesis of a branching structure GO:0001763
The process in which the anatomical structures of branches are generated and organized. A branch is a division or offshoot from a main stem. Examples in animals would include blood vessels, nerves, lymphatics and other endothelial or epithelial tubes.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cell activation GO:0001775
A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of protein phosphorylation GO:0001933
Any process that stops, prevents or reduces the rate of addition of phosphate groups to amino acids within a protein.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein phosphorylation GO:0001934
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of sodium ion transport GO:0002028
Any process that modulates the frequency, rate or extent of the directed movement of sodium ions (Na+) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Chondrocyte differentiation GO:0002062
The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Hematopoietic progenitor cell differentiation GO:0002244
The process in which precursor cell type acquires the specialized features of a hematopoietic progenitor cell, a class of cell types including myeloid progenitor cells and lymphoid progenitor cells.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Connective tissue replacement involved in inflammatory response wound healing GO:0002248
The series of events leading to growth of connective tissue when loss of tissues that are incapable of regeneration occurs, or when fibrinous exudate cannot be adequately cleared that contribute to an inflammatory response.
|
2 | P01137 (/TAS) P01137 (/TAS) |
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment GO:0002362
The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a CD4-positive, CD25-positive, alpha-beta regulatory T cell.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains GO:0002460
An immune response mediated by lymphocytes expressing specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains. Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies) produced by B cells. The first encounter with antigen elicits a primary immune response that is slow and not of great magnitude. T and B cells selected by antigen become activated and undergo clonal expansion. A fraction of antigen-reactive T and B cells become memory cells, whereas others differentiate into effector cells. The memory cells generated during the primary response enable a much faster and stronger secondary immune response upon subsequent exposures to the same antigen (immunological memory). An example of this is the adaptive immune response found in Mus musculus.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Tolerance induction to self antigen GO:0002513
Tolerance induction directed at self antigens.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Platelet degranulation GO:0002576
The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Heart valve morphogenesis GO:0003179
The process in which the structure of a heart valve is generated and organized.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Heart valve morphogenesis GO:0003179
The process in which the structure of a heart valve is generated and organized.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Aortic valve morphogenesis GO:0003180
The process in which the structure of the aortic valve is generated and organized.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Protein phosphorylation GO:0006468
The process of introducing a phosphate group on to a protein.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Protein export from nucleus GO:0006611
The directed movement of a protein from the nucleus into the cytoplasm.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Protein export from nucleus GO:0006611
The directed movement of a protein from the nucleus into the cytoplasm.
|
2 | P04202 (/ISO) P04202 (/ISO) |
ATP biosynthetic process GO:0006754
The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
2 | P01137 (/IDA) P01137 (/IDA) |
ATP biosynthetic process GO:0006754
The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Phosphate-containing compound metabolic process GO:0006796
The chemical reactions and pathways involving the phosphate group, the anion or salt of any phosphoric acid.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Phosphate-containing compound metabolic process GO:0006796
The chemical reactions and pathways involving the phosphate group, the anion or salt of any phosphoric acid.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cellular calcium ion homeostasis GO:0006874
Any process involved in the maintenance of an internal steady state of calcium ions at the level of a cell.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Defense response GO:0006952
Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Inflammatory response GO:0006954
The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
|
2 | P01137 (/IDA) P01137 (/IDA) |
Cell cycle arrest GO:0007050
A regulatory process that halts progression through the cell cycle during one of the normal phases (G1, S, G2, M).
|
2 | P04202 (/ISO) P04202 (/ISO) |
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Epidermal growth factor receptor signaling pathway GO:0007173
A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Transforming growth factor beta receptor signaling pathway GO:0007179
A series of molecular signals initiated by the binding of an extracellular ligand to a transforming growth factor beta receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Common-partner SMAD protein phosphorylation GO:0007182
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
SMAD protein complex assembly GO:0007183
The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
|
2 | P01137 (/IDA) P01137 (/IDA) |
SMAD protein complex assembly GO:0007183
The aggregation, arrangement and bonding together of a set of components to form a protein complex that contains SMAD proteins.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Notch signaling pathway GO:0007219
A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Negative regulation of neuroblast proliferation GO:0007406
Any process that stops, prevents, or reduces the frequency, rate or extent of the proliferation of neuroblasts.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
|
2 | P01137 (/IEP) P01137 (/IEP) |
Endoderm development GO:0007492
The process whose specific outcome is the progression of the endoderm over time, from its formation to the mature structure. The endoderm is the innermost germ layer that develops into the gastrointestinal tract, the lungs and associated tissues.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Heart development GO:0007507
The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Skeletal muscle tissue development GO:0007519
The developmental sequence of events leading to the formation of adult skeletal muscle tissue. The main events are: the fusion of myoblasts to form myotubes that increase in size by further fusion to them of myoblasts, the formation of myofibrils within their cytoplasm and the establishment of functional neuromuscular junctions with motor neurons. At this stage they can be regarded as mature muscle fibers.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Germ cell migration GO:0008354
The orderly movement of a cell specialized to produce haploid gametes through the embryo from its site of production to the place where the gonads will form.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Response to wounding GO:0009611
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism.
|
2 | P01137 (/IEP) P01137 (/IEP) |
Defense response to fungus, incompatible interaction GO:0009817
A response of an organism to a fungus that prevents the occurrence or spread of disease.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of gene expression GO:0010468
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of vascular endothelial growth factor production GO:0010575
Any process that increases or activates the frequency, rate, or extent of production of vascular endothelial growth factor.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Negative regulation of gene expression GO:0010629
Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of extracellular matrix disassembly GO:0010716
Any process that decreases the rate, frequency or extent of extracellular matrix disassembly. Extracellular matrix disassembly is a process that results in the breakdown of the extracellular matrix.
|
2 | P01137 (/IC) P01137 (/IC) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | P01137 (/NAS) P01137 (/NAS) |
Macrophage derived foam cell differentiation GO:0010742
The process in which a monocyte acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.
|
2 | P01137 (/IC) P01137 (/IC) |
Positive regulation of fibroblast migration GO:0010763
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of fibroblast migration GO:0010763
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of fibroblast migration GO:0010763
Any process that increases the rate, frequency or extent of fibroblast cell migration. Fibroblast cell migration is accomplished by extension and retraction of a pseudopodium.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of macrophage cytokine production GO:0010936
Any process that decreases the rate, frequency or extent of macrophage cytokine production. Macrophage cytokine production is the appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Oligodendrocyte development GO:0014003
The process aimed at the progression of an oligodendrocyte over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell. An oligodendrocyte is a type of glial cell involved in myelinating the axons in the central nervous system.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of microglia differentiation GO:0014008
Any process that activates, maintains or increases the frequency, rate or extent of microglia differentiation, the process in which a relatively unspecialized cell acquires specialized features of a microglial cell.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of striated muscle tissue development GO:0016202
Any process that modulates the frequency, rate or extent of striated muscle development.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Cell migration GO:0016477
The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of transforming growth factor beta receptor signaling pathway GO:0017015
Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Regulation of transforming growth factor beta receptor signaling pathway GO:0017015
Any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Evasion or tolerance of host defenses by virus GO:0019049
Any process, either active or passive, by which a virus avoids or tolerates the effects of its host organism's defense(s). Host defenses may be induced by the presence of the virus or may be preformed (e.g. physical barriers). The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Evasion or tolerance of host defenses by virus GO:0019049
Any process, either active or passive, by which a virus avoids or tolerates the effects of its host organism's defense(s). Host defenses may be induced by the presence of the virus or may be preformed (e.g. physical barriers). The host is defined as the larger of the organisms involved in a symbiotic interaction.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Neural tube development GO:0021915
The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Neural tube development GO:0021915
The process whose specific outcome is the progression of the neural tube over time, from its formation to the mature structure. The mature structure of the neural tube exists when the tube has been segmented into the forebrain, midbrain, hindbrain and spinal cord regions. In addition neural crest has budded away from the epithelium.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Negative regulation of cell-cell adhesion GO:0022408
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of cell-cell adhesion GO:0022408
Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Hyaluronan catabolic process GO:0030214
The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Hyaluronan catabolic process GO:0030214
The chemical reactions and pathways resulting in the breakdown of hyaluronan, the naturally occurring anionic form of hyaluronic acid, any member of a group of glycosaminoglycans, the repeat units of which consist of beta-1,4 linked D-glucuronyl-beta-(1,3)-N-acetyl-D-glucosamine.
|
2 | P04202 (/ISO) P04202 (/ISO) |
T cell differentiation GO:0030217
The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Negative regulation of ossification GO:0030279
Any process that stops, prevents, or reduces the frequency, rate or extent of ossification, the formation of bone or of a bony substance or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Negative regulation of cell growth GO:0030308
Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Osteoclast differentiation GO:0030316
The process in which a relatively unspecialized monocyte acquires the specialized features of an osteoclast. An osteoclast is a specialized phagocytic cell associated with the absorption and removal of the mineralized matrix of bone tissue.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Regulation of cell migration GO:0030334
Any process that modulates the frequency, rate or extent of cell migration.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Positive regulation of cell migration GO:0030335
Any process that activates or increases the frequency, rate or extent of cell migration.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
2 | P01137 (/IEP) P01137 (/IEP) |
Negative regulation of transforming growth factor beta receptor signaling pathway GO:0030512
Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Mammary gland development GO:0030879
The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of histone deacetylation GO:0031065
Any process that activates or increases the frequency, rate or extent of the removal of acetyl groups from histones.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Membrane protein intracellular domain proteolysis GO:0031293
The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Membrane protein intracellular domain proteolysis GO:0031293
The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein complex assembly GO:0031334
Any process that activates or increases the frequency, rate or extent of protein complex assembly.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of exit from mitosis GO:0031536
Any process that activates or increases the rate of progression from anaphase/telophase (high mitotic CDK activity) to G1 (low mitotic CDK activity).
|
2 | P04202 (/ISO) P04202 (/ISO) |
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of cellular protein metabolic process GO:0032270
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Response to progesterone GO:0032570
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a progesterone stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of interleukin-23 production GO:0032667
Any process that modulates the frequency, rate, or extent of interleukin-23 production.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Negative regulation of interleukin-17 production GO:0032700
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of interleukin-17 production GO:0032740
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Receptor catabolic process GO:0032801
The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Receptor catabolic process GO:0032801
The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation GO:0032829
Any process that modulates the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Positive regulation of superoxide anion generation GO:0032930
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of superoxide anion generation GO:0032930
Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Mononuclear cell proliferation GO:0032943
The expansion of a mononuclear cell population by cell division. A mononuclear cell is a leukocyte with a single non-segmented nucleus in the mature form.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Positive regulation of collagen biosynthetic process GO:0032967
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of peptidyl-serine phosphorylation GO:0033138
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of histone acetylation GO:0035066
Any process that activates or increases the frequency, rate or extent of the addition of an acetyl group to a histone protein.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of protein dephosphorylation GO:0035307
Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein dephosphorylation GO:0035307
Any process that activates or increases the frequency, rate or extent of removal of phosphate groups from a protein.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
2 | P04202 (/ISO) P04202 (/ISO) |
T cell activation GO:0042110
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
2 | P04202 (/IDA) P04202 (/IDA) |
T cell activation GO:0042110
The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Negative regulation of T cell proliferation GO:0042130
Any process that stops, prevents or reduces the rate or extent of T cell proliferation.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of protein import into nucleus GO:0042306
Any process that modulates the frequency, rate or extent of movement of proteins from the cytoplasm to the nucleus.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of protein import into nucleus GO:0042307
Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein import into nucleus GO:0042307
Any process that activates or increases the frequency, rate or extent of movement of proteins from the cytoplasm into the nucleus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of odontogenesis GO:0042482
Any process that activates or increases the frequency, rate or extent of the formation and development of a tooth or teeth.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Myelination GO:0042552
The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Myeloid dendritic cell differentiation GO:0043011
The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
|
2 | P04202 (/IMP) P04202 (/IMP) |
T cell homeostasis GO:0043029
The process of regulating the proliferation and elimination of T cells such that the total number of T cells within a whole or part of an organism is stable over time in the absence of an outside stimulus.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of vascular permeability GO:0043117
Any process that increases the extent to which blood vessels can be pervaded by fluid.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of MAP kinase activity GO:0043406
Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Protein kinase B signaling GO:0043491
A series of reactions, mediated by the intracellular serine/threonine kinase protein kinase B (also called AKT), which occurs as a result of a single trigger reaction or compound.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of blood vessel endothelial cell migration GO:0043536
Any process that activates or increases the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of blood vessel endothelial cell migration GO:0043537
Any process that stops, prevents, or reduces the frequency, rate or extent of the migration of the endothelial cells of blood vessels.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of phosphatidylinositol 3-kinase activity GO:0043552
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of phosphatidylinositol 3-kinase activity GO:0043552
Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Ossification involved in bone remodeling GO:0043932
The formation or growth of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone, involved in response to injury or other physical, physiological or environmental stress stimuli.
|
2 | P01137 (/IEP) P01137 (/IEP) |
Regulatory T cell differentiation GO:0045066
The process in which a relatively unspecialized T cell acquires specialized features of a regulatory T cell. Regulatory T cells control or suppress immune responses through a variety of mechanisms and subsets include the CD4+CD25+ cell type as well as certain CD8+ cell types.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Regulatory T cell differentiation GO:0045066
The process in which a relatively unspecialized T cell acquires specialized features of a regulatory T cell. Regulatory T cells control or suppress immune responses through a variety of mechanisms and subsets include the CD4+CD25+ cell type as well as certain CD8+ cell types.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Cell-cell junction organization GO:0045216
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a cell-cell junction. A cell-cell junction is a specialized region of connection between two cells.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of regulatory T cell differentiation GO:0045589
Any process that modulates the frequency, rate or extent of differentiation of regulatory T cells.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Positive regulation of regulatory T cell differentiation GO:0045591
Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Negative regulation of cell differentiation GO:0045596
Any process that stops, prevents, or reduces the frequency, rate or extent of cell differentiation.
|
2 | P01137 (/IEP) P01137 (/IEP) |
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of fat cell differentiation GO:0045599
Any process that stops, prevents, or reduces the frequency, rate or extent of adipocyte differentiation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of myoblast differentiation GO:0045662
Any process that stops, prevents, or reduces the frequency, rate or extent of myoblast differentiation. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into skeletal muscle fibers.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of cytolysis GO:0045918
Any process that stops, prevents, or reduces the frequency, rate or extent of cytolysis.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of cytolysis GO:0045918
Any process that stops, prevents, or reduces the frequency, rate or extent of cytolysis.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of mitotic cell cycle GO:0045930
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of mitotic cell cycle GO:0045930
Any process that stops, prevents or reduces the rate or extent of progression through the mitotic cell cycle.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Muscle cell cellular homeostasis GO:0046716
The cellular homeostatic process that preserves a muscle cell in a stable functional or structural state.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of isotype switching to IgA isotypes GO:0048298
Any process that activates or increases the frequency, rate or extent of isotype switching to IgA isotypes.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of isotype switching to IgA isotypes GO:0048298
Any process that activates or increases the frequency, rate or extent of isotype switching to IgA isotypes.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Lymph node development GO:0048535
The process whose specific outcome is the progression of lymph nodes over time, from their formation to the mature structure. A lymph node is a round, oval, or bean shaped structure localized in clusters along the lymphatic vessels, with a distinct internal structure including specialized vasculature and B- and T-zones for the activation of lymphocytes.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Negative regulation of skeletal muscle tissue development GO:0048642
Any process that stops, prevents, or reduces the frequency, rate or extent of skeletal muscle tissue development.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of skeletal muscle tissue development GO:0048642
Any process that stops, prevents, or reduces the frequency, rate or extent of skeletal muscle tissue development.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Negative regulation of epithelial cell proliferation GO:0050680
Any process that stops, prevents or reduces the rate or extent of epithelial cell proliferation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein secretion GO:0050714
Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of phagocytosis GO:0050765
Any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of immune response GO:0050777
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of T cell activation GO:0050868
Any process that stops, prevents, or reduces the frequency, rate or extent of T cell activation.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Leukocyte migration GO:0050900
The movement of a leukocyte within or between different tissues and organs of the body.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Positive regulation of chemotaxis GO:0050921
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of chemotaxis GO:0050921
Any process that activates or increases the frequency, rate or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of binding GO:0051098
Any process that modulates the frequency, rate or extent of binding, the selective interaction of a molecule with one or more specific sites on another molecule.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Regulation of DNA binding GO:0051101
Any process that modulates the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid).
|
2 | P04202 (/IDA) P04202 (/IDA) |
Positive regulation of smooth muscle cell differentiation GO:0051152
Any process that activates or increases the frequency, rate or extent of smooth muscle cell differentiation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of release of sequestered calcium ion into cytosol GO:0051280
Any process that stops, prevents, or reduces the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein kinase B signaling GO:0051897
Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Ventricular cardiac muscle tissue morphogenesis GO:0055010
The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Ventricular cardiac muscle tissue morphogenesis GO:0055010
The process in which the anatomical structures of cardiac ventricle muscle is generated and organized.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Regulation of blood vessel remodeling GO:0060312
Any process that modulates the rate, frequency or extent of blood vessel remodeling, the reorganization or renovation of existing blood vessels.
|
2 | P01137 (/IC) P01137 (/IC) |
Regulation of blood vessel remodeling GO:0060312
Any process that modulates the rate, frequency or extent of blood vessel remodeling, the reorganization or renovation of existing blood vessels.
|
2 | P01137 (/NAS) P01137 (/NAS) |
Face morphogenesis GO:0060325
The process in which the anatomical structures of the face are generated and organized. The face is the ventral division of the head.
|
2 | P04202 (/IEP) P04202 (/IEP) |
Pathway-restricted SMAD protein phosphorylation GO:0060389
The process of introducing a phosphate group on to a pathway restricted SMAD protein. A pathway restricted SMAD protein is an effector protein that acts directly downstream of the transforming growth factor family receptor.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of SMAD protein signal transduction GO:0060390
Any process that modulates the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Regulation of SMAD protein signal transduction GO:0060390
Any process that modulates the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of SMAD protein signal transduction GO:0060391
Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Mammary gland branching involved in thelarche GO:0060744
The process in which the branching structure of the mammary gland duct is generated and organized during the period of sexual maturity in mammals. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Branch elongation involved in mammary gland duct branching GO:0060751
The developmental growth process in which a branch of a mammary gland duct elongates.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Regulation of branching involved in mammary gland duct morphogenesis GO:0060762
Any process that modulates the rate, frequency, or extent of branching involved in mammary gland duct morphogenesis.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Negative regulation of gene silencing by miRNA GO:0060965
Any process that decreases the rate, frequency, or extent of gene silencing by miRNA.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Negative regulation of gene silencing by miRNA GO:0060965
Any process that decreases the rate, frequency, or extent of gene silencing by miRNA.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of cartilage development GO:0061035
Any process that modulates the rate, frequency, or extent of cartilage development, the process whose specific outcome is the progression of the cartilage over time, from its formation to the mature structure. Cartilage is a connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Connective tissue development GO:0061448
The progression of a connective tissue over time, from its formation to the mature structure.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Negative regulation of biomineral tissue development GO:0070168
Any process that stops, prevents, or reduces the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of biomineral tissue development GO:0070168
Any process that stops, prevents, or reduces the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Negative regulation of biomineral tissue development GO:0070168
Any process that stops, prevents, or reduces the frequency, rate or extent of biomineral tissue development, the formation of hard tissues that consist mainly of inorganic compounds.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Lens fiber cell differentiation GO:0070306
The process in which a relatively unspecialized cell acquires specialized features of a lens fiber cell, any of the elongated, tightly packed cells that make up the bulk of the mature lens in the camera-type eye. The cytoplasm of a lens fiber cell is devoid of most intracellular organelles including the cell nucleus, and contains primarily crystallins, a group of water-soluble proteins expressed in vary large quantities.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of ERK1 and ERK2 cascade GO:0070374
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Response to cholesterol GO:0070723
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cholesterol stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of cell cycle arrest GO:0071158
Any process that increases the rate, frequency, or extent of cell cycle arrest, the process in which the cell cycle is halted during one of the normal phases.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Cellular response to growth factor stimulus GO:0071363
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Cellular response to organic cyclic compound GO:0071407
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cellular response to dexamethasone stimulus GO:0071549
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Cellular response to transforming growth factor beta stimulus GO:0071560
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transforming growth factor beta stimulus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of mononuclear cell migration GO:0071677
Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.
|
2 | P04202 (/ISO) P04202 (/ISO) |
T-helper 17 cell lineage commitment GO:0072540
The process in which a CD4-positive, alpha-beta T cell becomes committed to becoming a T-helper 17 cell, a CD4-positive, alpha-beta T cell with the phenotype RORgamma-t-positive that produces IL-17.
|
2 | P04202 (/TAS) P04202 (/TAS) |
Extracellular matrix assembly GO:0085029
The aggregation, arrangement and bonding together of the extracellular matrix.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of branching involved in ureteric bud morphogenesis GO:0090190
Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Extrinsic apoptotic signaling pathway GO:0097191
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of hyaluronan biosynthetic process GO:1900126
Any process that stops, prevents or reduces the frequency, rate or extent of hyaluronan biosynthetic process.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of hyaluronan biosynthetic process GO:1900126
Any process that stops, prevents or reduces the frequency, rate or extent of hyaluronan biosynthetic process.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Positive regulation of protein localization to nucleus GO:1900182
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of extracellular matrix assembly GO:1901203
Any process that activates or increases the frequency, rate or extent of extracellular matrix assembly.
|
2 | P01137 (/IC) P01137 (/IC) |
Positive regulation of NAD+ ADP-ribosyltransferase activity GO:1901666
Any process that activates or increases the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of NAD+ ADP-ribosyltransferase activity GO:1901666
Any process that activates or increases the frequency, rate or extent of NAD+ ADP-ribosyltransferase activity.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of pri-miRNA transcription by RNA polymerase II GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of pri-miRNA transcription by RNA polymerase II GO:1902895
Any process that activates or increases the frequency, rate or extent of pri-miRNA transcription mediated by RNA polymerase II.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of protein localization to plasma membrane GO:1903077
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Negative regulation of protein localization to plasma membrane GO:1903077
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799
Any process that stops, prevents or reduces the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P01137 (/IGI) P01137 (/IGI) |
Negative regulation of production of miRNAs involved in gene silencing by miRNA GO:1903799
Any process that stops, prevents or reduces the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800
Any process that activates or increases the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of production of miRNAs involved in gene silencing by miRNA GO:1903800
Any process that activates or increases the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of receptor clustering GO:1903911
Any process that activates or increases the frequency, rate or extent of receptor clustering.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Transforming growth factor beta receptor signaling pathway involved in heart development GO:1905313
Any transforming growth factor beta receptor signaling pathway that is involved in heart development.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Transforming growth factor beta receptor signaling pathway involved in heart development GO:1905313
Any transforming growth factor beta receptor signaling pathway that is involved in heart development.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Embryonic liver development GO:1990402
The process occurring during the embryonic phase whose specific outcome is the progression of the liver over time, from its formation to the mature structure.
|
2 | P04202 (/IMP) P04202 (/IMP) |
Embryonic liver development GO:1990402
The process occurring during the embryonic phase whose specific outcome is the progression of the liver over time, from its formation to the mature structure.
|
2 | P01137 (/ISS) P01137 (/ISS) |
Regulation of actin cytoskeleton reorganization GO:2000249
Any process that modulates the frequency, rate or extent of actin cytoskeleton reorganization.
|
2 | P04202 (/IGI) P04202 (/IGI) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of transcription regulatory region DNA binding GO:2000679
Any process that activates or increases the frequency, rate or extent of transcription regulatory region DNA binding.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Positive regulation of cardiac muscle cell differentiation GO:2000727
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Positive regulation of cardiac muscle cell differentiation GO:2000727
Any process that activates or increases the frequency, rate or extent of cardiac muscle cell differentiation.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Regulation of cell growth GO:0001558
Any process that modulates the frequency, rate, extent or direction of cell growth.
|
1 | P17246 (/TAS) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P17246 (/IEP) |
Morphogenesis of a branching structure GO:0001763
The process in which the anatomical structures of branches are generated and organized. A branch is a division or offshoot from a main stem. Examples in animals would include blood vessels, nerves, lymphatics and other endothelial or epithelial tubes.
|
1 | P17246 (/IDA) |
Negative regulation of neuroblast proliferation GO:0007406
Any process that stops, prevents, or reduces the frequency, rate or extent of the proliferation of neuroblasts.
|
1 | P17246 (/IDA) |
Female pregnancy GO:0007565
The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth.
|
1 | P17246 (/IEP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | P17246 (/IEP) |
Response to radiation GO:0009314
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
|
1 | P17246 (/IEP) |
Response to glucose GO:0009749
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucose stimulus.
|
1 | P17246 (/IEP) |
Defense response to fungus, incompatible interaction GO:0009817
A response of an organism to a fungus that prevents the occurrence or spread of disease.
|
1 | P17246 (/IDA) |
Response to organic substance GO:0010033
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus.
|
1 | P17246 (/IDA) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
1 | P17246 (/IEP) |
Lung development GO:0030324
The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax.
|
1 | P17246 (/TAS) |
Animal organ regeneration GO:0031100
The regrowth of a lost or destroyed animal organ.
|
1 | P17246 (/IMP) |
Positive regulation of exit from mitosis GO:0031536
Any process that activates or increases the rate of progression from anaphase/telophase (high mitotic CDK activity) to G1 (low mitotic CDK activity).
|
1 | P17246 (/IDA) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
1 | P17246 (/IEP) |
Response to vitamin D GO:0033280
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.
|
1 | P17246 (/IEP) |
Positive regulation of mammary gland epithelial cell proliferation GO:0033601
Any process that activates or increases the rate or extent of mammary gland epithelial cell proliferation.
|
1 | P18341 (/IMP) |
Positive regulation of luteinizing hormone secretion GO:0033686
Any process that activates or increases the frequency, rate or extent of the regulated release of luteinizing hormone.
|
1 | P09531 (/IEP) |
Response to laminar fluid shear stress GO:0034616
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a laminar fluid shear stress stimulus. Laminar fluid flow is the force acting on an object in a system where the fluid is moving across a solid surface in parallel layers. As an example, laminar shear stress can be seen where blood flows against the luminal side of blood vessel walls.
|
1 | P17246 (/IEP) |
Response to immobilization stress GO:0035902
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of being rendered immobile.
|
1 | P17246 (/IEP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
1 | P17246 (/IEP) |
Wound healing GO:0042060
The series of events that restore integrity to a damaged tissue, following an injury.
|
1 | P17246 (/IMP) |
Regulation of cell population proliferation GO:0042127
Any process that modulates the frequency, rate or extent of cell proliferation.
|
1 | P17246 (/TAS) |
Positive regulation of phosphorylation GO:0042327
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
|
1 | P09531 (/IEP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P17246 (/IEP) |
Myelination GO:0042552
The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier.
|
1 | P17246 (/IMP) |
Progesterone secretion GO:0042701
The regulated release of progesterone, a steroid hormone, by the corpus luteum of the ovary and by the placenta.
|
1 | P09531 (/IEP) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
1 | P17246 (/IDA) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
1 | P17246 (/IMP) |
Positive regulation of follicle-stimulating hormone secretion GO:0046881
Any process that activates or increases the frequency, rate or extent of the regulated release of follicle-stimulating hormone.
|
1 | P09531 (/IEP) |
Positive regulation of fibroblast proliferation GO:0048146
Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
|
1 | P18341 (/IMP) |
Digestive tract development GO:0048565
The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed.
|
1 | P17246 (/IEP) |
Inner ear development GO:0048839
The process whose specific outcome is the progression of the inner ear over time, from its formation to the mature structure.
|
1 | P17246 (/IEP) |
Positive regulation of epithelial cell proliferation GO:0050679
Any process that activates or increases the rate or extent of epithelial cell proliferation.
|
1 | P17246 (/IDA) |
Regulation of protein secretion GO:0050708
Any process that modulates the frequency, rate or extent of the controlled release of a protein from a cell.
|
1 | P09531 (/IEP) |
Negative regulation of phagocytosis GO:0050765
Any process that stops, prevents, or reduces the frequency, rate or extent of phagocytosis.
|
1 | P17246 (/IDA) |
Negative regulation of immune response GO:0050777
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus.
|
1 | P17246 (/IDA) |
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
|
1 | P17246 (/IDA) |
Positive regulation of smooth muscle cell differentiation GO:0051152
Any process that activates or increases the frequency, rate or extent of smooth muscle cell differentiation.
|
1 | P17246 (/IDA) |
Negative regulation of release of sequestered calcium ion into cytosol GO:0051280
Any process that stops, prevents, or reduces the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.
|
1 | P17246 (/IDA) |
Frontal suture morphogenesis GO:0060364
The process in which the frontal suture is generated and organized.
|
1 | P17246 (/IEP) |
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
|
1 | P17246 (/IEP) |
Cellular response to ionizing radiation GO:0071479
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ionizing radiation stimulus. Ionizing radiation is radiation with sufficient energy to remove electrons from atoms and may arise from spontaneous decay of unstable isotopes, resulting in alpha and beta particles and gamma rays. Ionizing radiation also includes X-rays.
|
1 | P17246 (/IEP) |
Cellular response to dexamethasone stimulus GO:0071549
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
1 | P17246 (/IDA) |
Positive regulation of mononuclear cell migration GO:0071677
Any process that increases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body.
|
1 | P17246 (/IMP) |
Positive regulation of branching involved in ureteric bud morphogenesis GO:0090190
Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules.
|
1 | P17246 (/IMP) |
Liver regeneration GO:0097421
The regrowth of lost or destroyed liver.
|
1 | P17246 (/IEP) |
Response to salt GO:1902074
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a salt stimulus.
|
1 | P17246 (/IEP) |
Positive regulation of transdifferentiation GO:1903620
Any process that activates or increases the frequency, rate or extent of transdifferentiation.
|
1 | P18341 (/IMP) |
Cellular response to insulin-like growth factor stimulus GO:1990314
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin-like growth factor stimulus.
|
1 | P17246 (/IEP) |
There are 30 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Blood microparticle GO:0072562
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
|
63 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(53 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
62 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(52 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
58 |
E0A923 (/ISS)
E0A923 (/ISS)
E1BNK3 (/ISS)
E1BNK3 (/ISS)
E5LDB9 (/ISS)
F1PI70 (/ISS)
F1PI70 (/ISS)
F6K637 (/ISS)
F7HCV5 (/ISS)
G1LYW1 (/ISS)
(48 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
5 | P01137 (/IDA) P01137 (/IDA) P04202 (/IDA) P04202 (/IDA) P17246 (/IDA) |
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
|
4 | P01137 (/ISS) P01137 (/ISS) P07200 (/ISS) P18341 (/ISS) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
3 | P01137 (/TAS) P01137 (/TAS) P09533 (/TAS) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
3 | P01137 (/IDA) P01137 (/IDA) P17246 (/IDA) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
2 | P01137 (/IDA) P01137 (/IDA) |
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Golgi lumen GO:0005796
The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Plasma membrane GO:0005886
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | P01137 (/IMP) P01137 (/IMP) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Extracellular matrix GO:0031012
A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
|
2 | P04202 (/IDA) P04202 (/IDA) |
Platelet alpha granule lumen GO:0031093
The volume enclosed by the membrane of the platelet alpha granule.
|
2 | P01137 (/TAS) P01137 (/TAS) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
2 | P01137 (/HDA) P01137 (/HDA) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
2 | P04202 (/ISO) P04202 (/ISO) |
Blood microparticle GO:0072562
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
|
2 | P01137 (/HDA) P01137 (/HDA) |
Cell surface GO:0009986
The external part of the cell wall and/or plasma membrane.
|
1 | P17246 (/IDA) |
Secretory granule GO:0030141
A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
|
1 | P17246 (/IDA) |
Axon GO:0030424
The long process of a neuron that conducts nerve impulses, usually away from the cell body to the terminals and varicosities, which are sites of storage and release of neurotransmitter.
|
1 | P17246 (/IDA) |
Neuronal cell body GO:0043025
The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites.
|
1 | P17246 (/IDA) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
1 | P17246 (/IDA) |